Mammalian Target of Rapamycin Inhibition Decreases Angiotensin II-Induced Steroidogenesis in HAC15 Human

Yusuf Ali1,2, Elise P Gomez-Sanchez2, Celso E Gomez-Sanchez1,2

  • 1G. V. (Sonny) Montgomery, VA Medical Center, Jackson, MS, USA.

Endocrinology
|November 2, 2022
PubMed
Abstract

Insights

Mammalian target of rapamycin (mTOR) inhibitors reduce aldosterone and cortisol production by suppressing angiotensin II signaling in adrenal cells. This suggests mTOR inhibition may treat conditions with excessive steroid synthesis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mammalian target of rapamycin (mTOR) inhibitors are known to reduce adrenal cortical carcinoma cell proliferation and cortisol production.
  • The specific role of mTOR in aldosterone production, however, remained unexamined.

Purpose of the Study:

  • To investigate the role of mTOR signaling in aldosterone and cortisol production stimulated by angiotensin II (AngII) in HAC15 cells.
  • To evaluate the potential of mTOR inhibition as a therapeutic strategy for conditions involving excessive steroid synthesis.

Main Methods:

  • HAC15 cells were treated with an mTOR activator (MHY) and inhibitors (AZD8055), with or without AngII.
  • Expression and function of mTOR components (Raptor, Rictor) were analyzed, including knockdown via CRISPR/gRNA.
  • Effects on steroidogenic enzyme expression and signaling pathways (ERK, P70S6K, protein kinase B) were assessed.

Main Results:

  • mTOR inhibition by AZD8055 significantly suppressed AngII-induced aldosterone and cortisol production in a dose-dependent manner.
  • AZD8055 specifically targeted the AngII pathway, not forskolin-induced production, and reduced AngII-mediated ERK and mTOR activation.
  • Knockdown of mTOR components Raptor and Rictor attenuated AngII-induced steroid production, implicating mTOR complexes in this process.

Conclusions:

  • mTOR signaling is crucial for mediating AngII-induced aldosterone and cortisol synthesis in HAC15 cells.
  • Inhibiting mTOR presents a potential therapeutic approach for disorders characterized by excessive renin-angiotensin system-mediated steroid synthesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
831
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
487
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
762
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
2.7K